4307:TSENomura Research Institute,Ltd. Analysis

Nomura Research Institute (4307.T) is trading at ¥4,686, barely above the identified support of ¥4,650 and well below the resistance of ¥5,620, while the 20‑day SMA sits near ¥5,079, indicating limited upside in the near term. The MACD histogram is negative and the signal line is bearish, and the RSI of 42.9 suggests the stock is not yet oversold, reinforcing a neutral‑to‑bearish short‑term bias. Volatility is exceptionally high at 69% over the past 30 days and beta hovers around zero, implying price swings are driven more by company‑specific factors than market movements. Fundamentally, the stock appears dramatically overvalued: the trailing P/E of 175 dwarfs the industry average of 33, and the DCF‑derived fair value of ¥1,151 is less than a quarter of the current price. Revenue growth of 7.5% and solid operating margins are offset by a thin net profit margin of 2.2% and a payout ratio of nearly 290%, raising concerns about dividend sustainability. The balance sheet shows a debt‑to‑equity of 62%, which is moderate for the sector, but the company’s max drawdown of 44% highlights historical price weakness. Overall, the technical setup is neutral with a bearish tilt, and the valuation gap suggests the market has priced in expectations that are difficult to justify on the current fundamentals.
Given the high valuation, unsustainable dividend policy, and elevated volatility, a cautious stance is warranted. The medium‑ to long‑term outlook remains bearish unless the firm can substantially improve earnings quality or justify its premium through breakthrough growth. Investors should monitor the next support test and any shifts in earnings guidance before committing additional capital.